Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Current Assets (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Current Assets for 5 consecutive years, with $21.6 million as the latest value for Q3 2020.

  • Quarterly Current Assets fell 63.7% to $21.6 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $21.6 million through Sep 2020, down 63.7% year-over-year, with the annual reading at $7.5 million for FY2019, 92.32% down from the prior year.
  • Current Assets for Q3 2020 was $21.6 million at Forte Biosciences, down from $28.1 million in the prior quarter.
  • The five-year high for Current Assets was $109.6 million in Q2 2017, with the low at $7.5 million in Q4 2019.
  • Average Current Assets over 5 years is $62.0 million, with a median of $75.0 million recorded in 2018.
  • The sharpest move saw Current Assets skyrocketed 179.19% in 2017, then crashed 92.32% in 2019.
  • Over 5 years, Current Assets stood at $32.5 million in 2016, then surged by 179.19% to $90.6 million in 2017, then rose by 7.86% to $97.7 million in 2018, then plummeted by 92.32% to $7.5 million in 2019, then surged by 188.0% to $21.6 million in 2020.
  • According to Business Quant data, Current Assets over the past three periods came in at $21.6 million, $28.1 million, and $14.5 million for Q3 2020, Q2 2020, and Q1 2020 respectively.